Cowen and Company reiterated their buy rating on shares of Roche Holding Ltd. (NASDAQ:RHHBY) in a research report released on Tuesday morning. The firm currently has a $38.00 price objective on the stock.

RHHBY has been the topic of several other reports. Deutsche Bank AG lowered Roche Holding from a buy rating to a hold rating in a research report on Friday, July 7th. Morgan Stanley restated an equal weight rating on shares of Roche Holding in a research report on Wednesday, July 26th. Societe Generale lowered Roche Holding from a buy rating to a hold rating in a research report on Friday, June 30th. UBS AG lowered Roche Holding from a buy rating to a neutral rating in a research report on Thursday, July 6th. Finally, BNP Paribas restated a neutral rating on shares of Roche Holding in a research report on Tuesday, June 20th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and four have assigned a buy rating to the stock. Roche Holding currently has a consensus rating of Hold and an average target price of $37.00.

Shares of Roche Holding (NASDAQ RHHBY) traded up 0.03% during mid-day trading on Tuesday, hitting $32.05. The stock had a trading volume of 565,293 shares. The stock has a market cap of $218.78 billion and a price-to-earnings ratio of 21.69. Roche Holding has a 12-month low of $25.25 and a 12-month high of $36.82. The firm’s 50-day moving average price is $31.62 and its 200 day moving average price is $32.24.

COPYRIGHT VIOLATION NOTICE: This story was originally published by Daily Political and is owned by of Daily Political. If you are reading this story on another domain, it was illegally copied and reposted in violation of US & international copyright law. The legal version of this story can be read at https://www.dailypolitical.com/2017/09/22/roche-holdings-rhhby-buy-rating-reiterated-at-cowen-and-company.html.

Several large investors have recently bought and sold shares of RHHBY. Parametric Portfolio Associates LLC boosted its position in shares of Roche Holding by 12.3% in the 2nd quarter. Parametric Portfolio Associates LLC now owns 3,652,015 shares of the company’s stock worth $116,134,000 after purchasing an additional 400,190 shares during the last quarter. Capital Counsel LLC NY boosted its position in shares of Roche Holding by 30.5% in the 2nd quarter. Capital Counsel LLC NY now owns 1,428,387 shares of the company’s stock worth $45,423,000 after purchasing an additional 334,008 shares during the last quarter. Bristol John W & Co. Inc. NY boosted its position in shares of Roche Holding by 13.1% in the 2nd quarter. Bristol John W & Co. Inc. NY now owns 2,327,621 shares of the company’s stock worth $74,193,000 after purchasing an additional 269,099 shares during the last quarter. Schafer Cullen Capital Management Inc. boosted its position in shares of Roche Holding by 10.8% in the 1st quarter. Schafer Cullen Capital Management Inc. now owns 2,369,119 shares of the company’s stock worth $75,883,000 after purchasing an additional 230,620 shares during the last quarter. Finally, Icon Advisers Inc. Co. bought a new position in shares of Roche Holding in the 2nd quarter worth $4,617,000.

About Roche Holding

Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.

Analyst Recommendations for Roche Holding (NASDAQ:RHHBY)

Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.